Logotype for Syngene International Limited

Syngene International (SYNGENE) investor relations material

Syngene International Q2 25/26 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Syngene International Limited
Q2 25/26 earnings summary6 Nov, 2025

Executive summary

  • Q2 FY26 revenue from operations was INR 911 crore (Rs 9,106 Mn), up 2% year-on-year and 4% sequentially, with H1 revenue up 6% year-on-year.

  • Operating EBITDA for Q2 was INR 200 crore, margin at 22–23.2%, down from 27–28.8% last year; PAT was INR 67 crore (Rs 671 Mn), down 37% year-on-year.

  • Research services maintained growth momentum, outpacing CDMO, which was impacted by inventory correction in biologics manufacturing.

  • Secured first global phase III clinical trial from a U.S.-based biotech, expanding clinical trial footprint to Australia, New Zealand, UK, Sri Lanka, and Eastern Europe.

  • Achieved highest 'Green Certification' from My Green Lab and improved EcoVadis score to 74/100, ranking in the 91st percentile globally for sustainability.

Financial highlights

  • Q2 revenue from operations: INR 911 crore (Rs 9,106 Mn), up 2% YoY; H1 revenue up 6% YoY.

  • Operating EBITDA: INR 200 crore, margin at 22–23.2% (down from 27–28.8% last year).

  • PAT before exceptional items: INR 67 crore (Rs 671 Mn), down 37% YoY; H1 PAT INR 154 crore (Rs 1,538 Mn), down 4% YoY.

  • Net cash balance as of 30 Sep 2025: INR 1,018 crore (Rs 10,183 Mn).

  • Staff costs increased 13% YoY in Q2 and 14% in H1.

Outlook and guidance

  • Full-year guidance maintained: mid-single-digit revenue growth, mid-20s EBITDA margin, declining PAT.

  • Bayview biologics manufacturing facility in the U.S. on track for operationalization in H2 FY26.

  • Continued expansion of global clinical trial capabilities and biologics manufacturing expected to drive future growth.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Syngene International earnings date

Logotype for Syngene International Limited
Q3 25/2622 Jan, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Syngene International earnings date

Logotype for Syngene International Limited
Q3 25/2622 Jan, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Syngene International Ltd engages in the provision of contract research and manufacturing services to the pharmaceutical, nutrition, and plant biology industries. It offers a comprehensive range of services from discovery support to manufacture of life-enabling therapies. The company is involved in three principal activities: providing drug discovery research services; drug development services; and manufacture of active pharmaceutical ingredients & Intermediates, Recombinant proteins, Bioagrochemicals, Biosimilars & Biogenerics and also offering third party research & manufacturing services, including custom synthesis projects. The company was incorporated in 1993 and is headquartered in Bengaluru, India.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage